Search

Theragnostic Imaging

Theragnostic Imaging

News
People
Events
Publications
RNTreg
Contact

Anne Catrine Martinsen

Latest

Myelosuppression in patients treated with 177Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable

© 2025 Me. This work is licensed under CC BY NC ND 4.0

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.